Radiotherapy of lung cancer: Technology meets biology meets multidisciplinarity

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 279-281

  Baumann, Michael ^a   Zips, Daniel ^a   Appold, Steffen ^a  

^a Helmholtz Zentrum Dresden Rossendorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR REGRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; RADIOSURGERY; RADIOTHERAPY; SMALL CELL LUNG CARCINOMA;

EID: 65749092105     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.001     Document Type: Editorial

References (66)

1. Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiother Oncol 83 (2007) 203-213
2. Bayman N.A., Sheikh H., Kularatne B., et al. Radiotherapy for small-cell lung cancer-where are we heading?. Lung Cancer 63 (2009) 307-314
3. van Meerbeeck J.P., Meersschout S., De Pauw R., Madani I., and De Neve W. Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospects. Oncologist 13 (2008) 700-708
4. Blackstock A.W., and Govindan R. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. J Clin Oncol 25 (2007) 4146-4152
5. Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350 (1997) 161-165
6. Pignon J.P., Tribodet H., Scagliotti G.V., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26 (2008) 3552-3559
7. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. Bmj 1995;311:899-909.
8. Rolland E., Pechoux L., Curran W.J., et al. Concomitant radiochemotherapy (CT-RT) versus sequential CT-RT in locally advanced non-small cell lung cancer: a meta-analysis using individual patient data from randomised trials. Int J Radiat Oncol Biol Phys Suppl. (2007) S9
9. Baumann P., Nyman J., Hoyer M., et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88 (2008) 359-367
10. Macmanus M., Nestle U., Rosenzweig K.E., et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 91 (2009) 85-94
11. Schutze C., Bergmann R., Yaromina A., et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol 83 (2007) 311-315
12. van Loon J., Offermann C., Bosmans G., et al. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 87 (2008) 49-54
13. Lavrenkov K., Christian J.A., Partridge M., et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol 83 (2007) 156-162
14. Ehler E.D., and Tome W.A. Lung 4D-IMRT treatment planning: an evaluation of three methods applied to four-dimensional data sets. Radiother Oncol 88 (2008) 319-325
15. Jin J.Y., Ajlouni M., Kong F.M., et al. Utilize target motion to cover clinical target volume (ctv)-a novel and practical treatment planning approach to manage respiratory motion. Radiother Oncol 89 (2008) 292-303
16. Spoelstra F.O., van Sornsen de Koste J.R., Cuijpers J.P., et al. Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors. Radiother Oncol 87 (2008) 59-64
17. Panakis N., McNair H.A., Christian J.A., et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiother Oncol 87 (2008) 65-73
18. Caldwell C.B., Mah K., Ung Y.C., et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
19. Elmpt W., Ollers M., Velders M., et al. Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol. Radiother Oncol 88 (2008) 326-334
20. Cattaneo G.M., Dell'oca I., Broggi S., et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol 88 (2008) 310-318
21. Wu J., Li H., Shekhar R., Suntharalingam M., and D'Souza W. An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors. Radiother Oncol 87 (2008) 35-43
22. Sura S., Gupta V., Yorke E., et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol 87 (2008) 17-23
23. Yom S.S., Liao Z., Liu H.H., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 94-102
24. Bragg C.M., Wingate K., and Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol 86 (2008) 276-284
25. Morgan A.M., Knoos T., McNee S.G., Evans C.J., and Thwaites D.I. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol 86 (2008) 48-54
26. Kepka L., Bujko K., Garmol D., et al. Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. Radiother Oncol 85 (2007) 450-455
27. Underberg R.W., Lagerwaard F.J., Slotman B.J., Cuijpers J.P., and Senan S. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 62 (2005) 554-560
28. Georg D., Hillbrand M., Stock M., Dieckmann K., and Potter R. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol 88 (2008) 368-375
29. Widesott L., Amichetti M., and Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol 86 (2008) 154-164
30. Hui Z., Zhang X., Starkschall G., et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 72 (2008) 1385-1395
31. Guckenberger M., Meyer J., Wilbert J., et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83 (2007) 57-64
32. Korreman S.S., Juhler-Nottrup T., and Boyer A.L. Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance. Radiother Oncol 86 (2008) 61-68
33. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
34. Gillham C., Zips D., Ponisch F., et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?. Radiother Oncol 88 (2008) 335-341
35. Spoelstra F.O., Pantarotto J.R., van Sornsen de Koste J.R., Slotman B.J., and Senan S. Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial. Int J Radiat Oncol Biol Phys (2009) 10.1016/j.ijroop.2008.12.027
36. Feng M., Kong F.M., Gross M., et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 73 (2009) 1228-1234
37. Moreno-Jimenez M., Aristu J., Lopez-Picazo J.M., et al. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Radiother Oncol 88 (2008) 342-350
38. Aerts H.J., van Baardwijk A.A., Petit S.F., et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 91 (2009) 386-392
39. Petit S.F., Aerts H.J., van Loon J.G., et al. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. Radiother Oncol 91 (2009) 393-398
40. Abramyuk A., Tokalov S., Zophel K., et al. Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?. Radiother Oncol 91 (2009) 399-404
41. Bral S., Duchateau M., De Ridder M., et al. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC. Radiother Oncol 91 (2009) 438-442
42. Rose J., Rodrigues G., Yaremko B., Lock M., and D'Souza D. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 91 (2009) 282-287
43. Borst G.R., Ishikawa M., Nijkamp J., et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol 91 (2009) 307-313
44. De Ruysscher D., Houben A., Aerts H.J., et al. Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study. Radiother Oncol 91 (2009) 415-420
45. Jin H., Tucker S.L., Liu H.H., et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91 (2009) 427-432
46. Dehing-Oberije C., Ruysscher D.D., Baardwijk A.V., et al. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 91 (2009) 421-426
47. Pettersson N., Nyman J., and Johansson K.A. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis. Radiother Oncol 91 (2009) 360-368
48. Gay H.A., Sibata C.H., Allison R.R., and Jeremic B. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy. Radiother Oncol 91 (2009) 369-378
49. De Ruysscher D., Dehing C., Yu S., et al. Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. Radiother Oncol 91 (2009) 353-359
50. Pijls-Johannesma M., Houben R., Boersma L., et al. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 91 (2009) 443-448
51. Guckenberger M., Krieger T., Richter A., et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 91 (2009) 288-295
52. van der Voort van Zyp N.C., Prevost J.B., Hoogeman M.S., et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome. Radiother Oncol 91 (2009) 296-300
53. Milano M.T., Chen Y., Katz A.W., et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother Oncol 91 (2009) 301-306
54. Wang L., Hayes S., Paskalev K., et al. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: Evaluation of the impact on daily dose coverage. Radiother Oncol 91 (2009) 314-324
55. Hughes S., McClelland J., Tarte S., et al. Assessment of two novel ventilatory surrogates for use in the delivery of gated/tracked radiotherapy for non-small cell lung cancer. Radiother Oncol 91 (2009) 336-341
56. Linthout N., Bral S., Van de Vondel I., et al. Treatment delivery time optimization of respiratory gated radiation therapy by application of audio-visual feedback. Radiother Oncol 91 (2009) 330-335
57. Partridge M., Tree A., Brock J., et al. Improvement in tumour control probability with active breathing control and dose escalation: A modelling study. Radiother Oncol 91 (2009) 325-329
58. Dinkel J., Hintze C., Tetzlaff R., et al. 4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis. Radiother Oncol 91 (2009) 449-454
59. Rosenzweig KE, Sura S, Jackson A, Yorke E. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 2007.
60. Yuan S., Sun X., Li M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
61. Sanuki-Fujimoto N., Sumi M., Ito Y., et al. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses. Radiother Oncol 91 (2009) 433-437
62. St-Hilaire J., Sevigny C., Beaulieu F., et al. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients. Radiother Oncol 91 (2009) 342-348
63. Lavrenkov K., Singh S., Christian J.A., et al. Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): An update of a planning study. Radiother Oncol 91 (2009) 349-352
64. Vorwerk H., Beckmann G., Bremer M., et al. The delineation of target volumes for radiotherapy of lung cancer patients. Radiother Oncol 91 (2009) 455-460
65. Aarup L.R., Nahum A.E., Zacharatou C., et al. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage. Radiother Oncol 91 (2009) 405-414
66. Arvidson N.B., Khuntia D., and Tome W.A. Dose escalation model for limited-stage small-cell lung cancer. Radiother Oncol 91 (2009) 379-385